Globe Life (NYSE:GL) Issues Earnings Results, Misses Expectations By $0.05 EPS

Globe Life (NYSE:GLGet Free Report) posted its quarterly earnings results on Wednesday. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05), Zacks reports. The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.81% and a net margin of 19.36%.The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period last year, the company earned $3.14 EPS. Globe Life updated its FY 2026 guidance to 14.950-15.650 EPS.

Globe Life Trading Up 2.4%

Shares of GL stock traded up $3.54 on Thursday, reaching $148.36. 241,002 shares of the stock were exchanged, compared to its average volume of 515,737. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life has a one year low of $109.38 and a one year high of $152.71. The stock has a market cap of $11.81 billion, a PE ratio of 10.76 and a beta of 0.47. The stock has a 50 day moving average price of $138.89 and a 200 day moving average price of $137.73.

Analysts Set New Price Targets

Several equities analysts recently commented on GL shares. Truist Financial raised their target price on Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Keefe, Bruyette & Woods upped their price objective on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Morgan Stanley restated an “overweight” rating and set a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Finally, Weiss Ratings cut Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, January 14th. Seven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Globe Life presently has a consensus rating of “Moderate Buy” and a consensus price target of $166.22.

Get Our Latest Stock Analysis on Globe Life

Key Headlines Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

  • Positive Sentiment: Q4 operating and net income showed year-over-year improvement and strong profitability (ROE ~21.8%, net margin ~19.4%), supporting the company’s earnings quality. GLOBE LIFE INC. REPORTS FOURTH QUARTER 2025 RESULTS
  • Positive Sentiment: Globe Life set FY‑2026 EPS guidance at $14.95–$15.65; the midpoint (~$15.30) is above the consensus estimate (~$15.03), which investors can interpret as upside to consensus next‑year earnings. GLOBE LIFE INC. REPORTS FOURTH QUARTER 2025 RESULTS
  • Neutral Sentiment: Brand/visibility items: events at Globe Life Field (college baseball scheduling and features) raise local visibility for the Globe Life name but are unlikely to move fundamentals materially. Baseball Game vs. NMSU Moved to Globe Life Field
  • Negative Sentiment: Quarterly EPS ($3.39) missed consensus by ~$0.05 and revenue ($1.52B) was ~$0.01B below estimates — headlines emphasize sales/earnings lagging expectations, which can pressure short‑term sentiment. Globe Life (GL) Q4 Earnings and Revenues Lag Estimates
  • Negative Sentiment: Multiple outlets highlight the miss and slower-than-expected top‑line growth (revenue +3.6% YoY), which could keep volatility in the shares while analysts digest full results and the guidance range. Globe Life reports sales below analyst estimates

Insider Buying and Selling

In related news, CEO Frank M. Svoboda sold 9,379 shares of Globe Life stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the sale, the chief executive officer directly owned 35,868 shares in the company, valued at $5,036,943.24. This trade represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.51% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Globe Life

Several institutional investors have recently modified their holdings of GL. CYBER HORNET ETFs LLC bought a new position in Globe Life in the second quarter valued at approximately $28,000. MUFG Securities EMEA plc acquired a new position in shares of Globe Life in the 2nd quarter valued at $31,000. Banque Cantonale Vaudoise acquired a new position in shares of Globe Life in the 3rd quarter valued at $50,000. Advisory Services Network LLC bought a new position in shares of Globe Life in the 3rd quarter worth $72,000. Finally, Headlands Technologies LLC grew its stake in shares of Globe Life by 893.6% during the second quarter. Headlands Technologies LLC now owns 775 shares of the company’s stock worth $96,000 after purchasing an additional 697 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

About Globe Life

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Read More

Earnings History for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.